Estadístiques de Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045
Visites totals
views | |
---|---|
Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 | 129 |
Visites totals per mes
views | |
---|---|
October 2024 | 0 |
November 2024 | 1 |
December 2024 | 1 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
Visites al fitxer
views | |
---|---|
nishiyama-ico-prem.pdf(legacy) | 89 |
nishiyama-ico-prem.pdf | 26 |
Vistes principals per país
views | |
---|---|
United States | 94 |
Sweden | 9 |
Spain | 8 |
India | 3 |
Germany | 2 |
Iran | 2 |
Japan | 2 |
Belgium | 1 |
Bulgaria | 1 |
Canada | 1 |
United Kingdom | 1 |
Malaysia | 1 |
Russia | 1 |
Visites principals per ciutat
views | |
---|---|
San Ramon | 38 |
Boardman | 6 |
Mountain View | 6 |
Ann Arbor | 5 |
Fairfield | 5 |
Menlo Park | 5 |
Tustin | 5 |
Almería | 2 |
Ashburn | 2 |
Barcelona | 2 |
Redwood City | 2 |
San Diego | 2 |
Tsukuba | 2 |
Cambridge | 1 |
Consuegra | 1 |
Madrid | 1 |
Mumbai | 1 |
Saint Catharines | 1 |
Shah Alam | 1 |
Stockport | 1 |